A2451 - Aclidinium Bromide Added to a Long-Acting B2-Agonist +/- Inhaled Corticosteroid: Effects on Exacerbations, Lung Function, and Symptoms in Patients with Chronic Obstructive Pulmonary Disease and Cardiovascular Risk Factors (ASCENT-COPD)
Presenter:
Date
05/19/2019
Room
Room C141/C143/C149 (Level 1), KBHCCD
Session Name
A102 - COPD: THERAPY
A1803 - When Mary Jane and Joe Camel Meet...Eosinophilic Sparks Are Born
Presenter:
Date
05/19/2019
Room
Area H (Hall F, Level 2), KBHCCD
Session Name
A49 - CASE REPORTS IN LUNG DISEASE ASSOCIATED WITH INHALATIONAL EXPOSURES
Authors
A1477 - Hypereosinophilic Syndrome with Acute Respiratory Failure Due to Severe Obstructive Airway Disease in a Patient Receiving Pembrolizumab
Presenter:
Date
05/19/2019
Room
Area D (Hall F, Level 2), KBHCCD
Session Name
A39 - DRUG RELATED CASE REPORTS
Authors
A3505 - Advance Cardiogenic Shock Management in a Post Liver Transplant Patient, a Novel Approach to Guide Therapy
Presenter:
Date
05/20/2019
Room
Area F (Hall F, Level 2), KBHCCD
Session Name
B51 - CRITICAL CARE CASE REPORTS: CARDIOVASCULAR DISEASES IN THE ICU II
Authors
A6080 - Exploring the Shared Molecular Networks of COPD and Idiopathic Pulmonary Fibrosis Reveals Concordant and Discordant Pathways in the Interactome
Presenter:
Date
05/22/2019
Room
Room D222-D224 (Level 2), KBHCCD
Session Name
D29 - LUNG MULTI-OMICS TO MECHANISM
A6323 - Erdheim-Chester Disease Presenting with Spontaneous Pneumothorax
Presenter:
Date
05/22/2019
Room
Area D (Hall F, Level 2), KBHCCD
Session Name
D39 - RARE DPLD CASE REPORTS
Authors
A4773 - A Multicenter Study for the Evaluation of Effectiveness and Safety of Nintendanib in the Treatment of Idiopathic Pulmonary Fibrosis
Presenter:
Date
05/21/2019
Room
Area H (Hall F, Level 2), KBHCCD
Session Name
C39 - IDIOPATHIC INTERSTITIAL PNEUMONIA: THERAPY
A7286 - MAP THE GAP: Mapping the Incidence and Mortality of Lung Cancer to Physician Distribution Across the United States
Presenter:
Date
05/22/2019
Room
Arena (Level 2), KBHCCD
Session Name
D110 - LUNG CANCER: OPTIMIZING SCREENING, DIAGNOSIS, AND TREATMENT
A3321 - Pharmacokinetics and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate in Adults with Moderate-to-Severe Chronic Obstructive Pulmonary Disease: A Phase I, Open-Label, Single-Center Study
Presenter:
Date
05/20/2019
Room
Area D (Hall F, Level 2), KBHCCD
Session Name
B45 - COPD: TREATMENT
Authors
A5067 - A Single Center Experience of Transitioning Stable Pulmonary Arterial Hypertension Patients from Parenteral Prostacyclin Therapy to Oral Selexipag
Presenter:
Date
05/21/2019
Room
Area J (Hall F, Level 2), KBHCCD
Session Name
C51 - CLOSER TO THE HEART: UPDATE ON APPROVED THERAPIES FOR PAH
A4152 - Increasing Communication and Trust in the ICU: The Critical Care Collaboration and Communication (C4) Project
Presenter:
Date
05/20/2019
Room
Trinity Ballroom 5-7 (Level 3), Omni Dallas Downtown
Session Name
B106 - CRITICAL CARE: A HUNDRED YEARS OF SOLITUDE - CARING FOR THE VULNERABLE: PATIENT, FAMILY, AND HCP-CENTERED CARE
Authors